Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
Background. Convalescent plasma obtained from individuals who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains neutralizing antibodies to the virus and has been frequently used as a treatment in hospitalized patients with severe COVID-19. Methods. We conducte...
Saved in:
| Main Authors: | Wesley V Cain, Anne M Sill, Vinod Solipuram, John J Weiss, Carole B Miller, Peter F Jelsma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2022/7992927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
by: Trishul Siddharthan, et al.
Published: (2021-01-01) -
Efficacy of convalescent plasma therapy in improving survival in non-immunized COVID-19 patients
by: Tania Portella Costa, et al.
Published: (2025-06-01) -
Efficacy of COVID convalescent plasma therapy in hospitalized moderate coronavirus disease 2019 patients
by: Cosphiadi Irawan, et al.
Published: (2023-01-01) -
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2
by: Andy Kwan Pui Chan, et al.
Published: (2025-07-01) -
Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma
by: William R. Hartman, et al.
Published: (2020-01-01)